26
|
Noh G, Nam J, Chung S, Kim K, Lee R. P-349 Clinical significance of lymph node radio to predict prognosis in colon cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
27
|
Duquenne L, Mankia K, Garcia-Montoya L, Nam J, Di Matteo A, Emery P. OP0112 IN INDIVIDUALS AT RISK OF INFLAMMATORY ARTHRITIS, PATIENT REPORTED OUTCOMES DETERIORATE IN THE 12 WEEKS BEFORE PROGRESSION TO CLINICAL DISEASE. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.2427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Subjects with clinically significant arthralgia who will eventually develop inflammatory arthritis (IA) had a higher HAQ at baseline (1). Here we investigated the change in patients reported outcomes (PRO) over time in ACPA+ at risk of IA subjects.Objectives:In ACPA+ subjects at risk of developing IA, to analyse the change in PRO results in order to identify an imminent phase of progression.Methods:In a single centre prospective observational cohort, PRO from 109 ACPA+ subjects without clinical arthritis were collected prospectively at 0, 12, 26, 39 weeks; the last time-point was 52 weeks for the individuals who did not progress to IA (non-progressors) or the last visit preceding progression (within 12 weeks) for those who developed IA (progressors). Data on the following PRO were collected: HAQ, “general health” (GH-VAS), “fatigue” (fatigue-VAS), and “global pain” (GP-VAS) using visual analogic scale measures graded 0 to 100. We firstly used mixed models repeated measures ANOVA analysis then included covariates such as gender, shared epitope (SE) (HLA DRB1*01, *04 and/or *10), anti-CCP2 antibody (CCP2) and/or rheumatoid factor (RF) high titre (≥3ULN), and smoking exposure (Ever/Never).Results:All analysis met sphericity assumption. In this selection, 20% of subjects (24/109) developed IA within a median of 77 weeks (Range 37-369.43), non-progressors were followed for a median of 216 weeks (Range 50-590), 74 subjects were SE positive (68%), 81 had a CCP2 and/or RF high titre (74%), and 66 were previous or current smokers (61%).Analysis revealed significant differences between both groups for the last visit, and within the progressor group for the last visit compared to all previous visits regarding the GH-VAS, GP-VAS and HAQ (Table 1, figure 1). Between subject analysis showed a significant influence of GH-VAS and GP-VAS change on progression. Covariate analysis showed a significant influence of previous smoking history on HAQ results (p=0.033, F=2.645 (4,408), Eta = 0.025).Table 1.Mixed Models repeated measuresGeneral HealthGlobal PainHAQFatigueWithin subject effects;VAS change over time depending on group.P= 0.004F(4, 428) = 3.883Partial Eta Square= 0.35P < 0.001F(4, 400) = 5.754Partial Eta Squared = 0.054P = 0.115P = 0.459Pairwise comparison within groupNon-progressors:all p > 0.05Non-progressors:all p > 0.05Non-progressors:all p > 0.05Non-progressors:all p > 0.05Progressors:Time-point 1 to 5:p = 0.010SE = 4.199Time-point 2 to 5:p = 0.001SE = 4.709Time-point 3 to 5:P = 0.001SE = 3.842Time-point 4 to 5:P = 0.043SE = 4.239Progressors:Time-point 1 to 5:p < 0.001SE = 6.172Time-point 2 to 5:p < 0.001SE = 5.518Time-point 3 to 5:P = 0.002SE = 5.246Time-point 4 to 5:P = 0.001SE = 5.333Progressors:Time-point 1 to 5:p = 0.215Time-point 2 to 5:P = 0.036SE = 0.068Time-point 3 to 5:P = 0.040SE = 0.062Time-point 4 to 5:P = 0.017SE = 0.066Progressors:Time-point 1 to 5:p = 0.448Time-point 2 to 5:P =0.292Time-point 3 to 5:P = 0.047SE = 5.421Time-point 4 to 5:P = 0.202Pairwise comparison between groupLast visit:P = 0.009SE = 5.454All other visits:P > 0.05Last visit:P = 0.003SE = 7.082All other visits:P > 0.05Last visit:P = 0.016SE = 0.119All other visits:P > 0.05P-value > 0.05Mauchly’s test of sphericityP = 0.099P = 0.050P = 0.057P = 0.722N (Progressors/total)24/10915/10224/10719/102Figure 1.Repeated measure ANOVA between groupsConclusion:These results show for the first time a significant deterioration in the PRO of general health, global pain, and HAQ weeks just preceding clinical arthritis development. This phase prior progression needs to be thoroughly studied to improve the accuracy of predicting imminent progression.References:[1]Ten Brinck RM et al. Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal study. RMD open. 2017;3(1):e000419.Disclosure of Interests:Laurence Duquenne: None declared, Kulveer Mankia: None declared, Leticia Garcia-Montoya: None declared, Jacqueline Nam: None declared, Andrea Di Matteo Grant/research support from: the publication was conducted while Dr. Di Matteo was an ARTICULUM fellow, Paul Emery Grant/research support from: AbbVie, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, Roche (all paid to employer), Consultant of: AbbVie (consultant, clinical trials, advisor), Bristol-Myers Squibb (consultant, clinical trials, advisor), Lilly (clinical trials, advisor), Merck Sharp & Dohme (consultant, clinical trials, advisor), Novartis (consultant, clinical trials, advisor), Pfizer (consultant, clinical trials, advisor), Roche (consultant, clinical trials, advisor), Samsung (clinical trials, advisor), Sandoz (clinical trials, advisor), UCB (consultant, clinical trials, advisor)
Collapse
|
28
|
Duquenne L, Nam J, Mankia K, Garcia-Montoya L, DI Matteo A, Emery P. FRI0036 VALIDATION OF RISK SCORES FOR PREDICTING PROGRESSION IN INDIVIDUALS “AT RISK OF RHEUMATOID ARTHRITIS”. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Composite scores for risk of progression were described in 2015 in a cohort of 100 anti-cyclic citrullinated peptide (anti-CCP) + individuals at risk of developing Inflammatory Arthritis (IA) (1). The first score, designed for primary care, was based on anti-CCP and rheumatoid factor (RF) titres, small joints tenderness and early morning stiffness (EMS). A second score developed for secondary care added power Doppler presence (PD+) and/or at least one allele positive for the shared epitope (SE+).Objectives:To validate previous data by scoring risk factors in a new cohort of 394 individuals.Methods:Individuals at risk of developing IA selected by a positive anti-CCP test and a new musculoskeletal symptom have been followed in a single-centre prospective observational cohort since 2008. The previous risk score was derived from 100 patients. With the same recruitment and follow-up pathways, the next 394 consecutive participants were studied (full data were available for 373 patients for secondary care model). Participants followed for less than 10 weeks without progression were excluded.Results:Participants from both cohorts were similar in terms of age and sex. Although the mean time to progression is comparable, there were significantly more participants with a high titre anti-CCP test in the 2015 cohort (Table 1).Table 1.Patients characteristicsScore20152020N100394Percentage of progression n/N50/100 (50%)82/413 (19.9%)Mean of follow-up before progression to IA (Months (SD))15.35 (15.27)13.50 (12.62)Mean follow-up of non progressors (Months (SD))39.7 (15.82)27.6 (19.75)Mean follow-up duration: all participants (Months (SD))27.7(19.36)24.8 (19.38)High CCP titre83%65%Women72%72%Smoker ever72%50%Age (Mean (SD))51.2 (11.9)50.2 (13.474)Cox multivariable analysis showed similar Hazard Ratios (HR) of progression in both groups (Table 2) confirming the high predictive value of high CCP/RF titre, early morning stiffness duration, power doppler presence and shared epitope. High risk of progression individuals identified by the secondary score were eight times more likely to develop IA (HR = 8.290, CI = 3.763-18.264, p<0.001), 50% of them had progressed at 2 years (Figure 1).Table 2.Multivariable Cox regression analysis of time to progression to inflammatory arthritis.2015 (n=98)2020 (n=394)Primary care modelHRp-valueCIHRp-valueCIHigh anti-CCP or RF titre4.860.0311.16−20.434.96<0.0011.445−3.526EMS≥30min1.860.0391.03−3.372.26<0.0011.445−3.526Small Joints Tenderness1.420.2520.78−2.571.300.2490.832−2.0352015 (n=98)2020 (n=373)Secondary care modelHRp-valueCIHRp-valueCIHigh anti-CCP or RF titre3.040.1470.68−13.63.920.0011.790−8.567EMS≥30min1.560.1670.83−2.922.100.0021.314−3.357Small Joints Tenderness1.540.1780.82−2.881.340.2160.843−2.135PD signal1.920.0331.06−3.502.350.0011.424−3.887Shared epitope1.570.2720.70−3.492.330.0031.333−4.059Figure 1.Probability of IA free survival according to categories of risk in the secondary care model.Conclusion:These data from a new large cohort confirm the validity previous Leeds Risk Scores for Primary and Secondary care, and the fidelity of the risk factors over time to predict progression.References:[1]Rakieh C, Nam JL, Hunt L, Hensor EM, Das S, Bissell LA, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Annals of the rheumatic diseases. 2015;74(9):1659-66.Disclosure of Interests:Laurence Duquenne: None declared, Jacqueline Nam: None declared, Kulveer Mankia: None declared, Leticia Garcia-Montoya: None declared, Andrea Di Matteo Grant/research support from: the publication was conducted while Dr. Di Matteo was an ARTICULUM fellow, Paul Emery Grant/research support from: AbbVie, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, Roche (all paid to employer), Consultant of: AbbVie (consultant, clinical trials, advisor), Bristol-Myers Squibb (consultant, clinical trials, advisor), Lilly (clinical trials, advisor), Merck Sharp & Dohme (consultant, clinical trials, advisor), Novartis (consultant, clinical trials, advisor), Pfizer (consultant, clinical trials, advisor), Roche (consultant, clinical trials, advisor), Samsung (clinical trials, advisor), Sandoz (clinical trials, advisor), UCB (consultant, clinical trials, advisor)
Collapse
|
29
|
DI Matteo A, Mankia K, Duquenne L, Cipolletta E, Wakefield R, Nam J, Garcia-Montoya L, Emery P. FRI0557 IN INDIVIDUALS AT-RISK OF RHEUMATOID ARTHRITIS, ULTRASOUND BONE EROSIONS AT THE V METATARSOPHALANGEAL JOINTS ARE THE MOST PREDICTIVE FOR THE DEVELOPMENT OF CLINICAL ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:While the central role of bone erosions in the pathogenesis and diagnosis of patients with rheumatoid arthritis (RA) is widely recognized, their prevalence, pattern, and relationship with subclinical synovitis in individuals at-risk of RA (positive autoantibodies without clinical arthritis) is not well understood.Objectives:To investigate, in individuals at-risk of RA, the prevalence and distribution of ultrasound (US) bone erosions, their correlation with subclinical synovitis at joint level, and their association with the development of inflammatory arthritis (IA).Methods:Baseline US scans of 2ndgeneration anti-cyclic citrullinated peptide (CCP) positive at-risk subjects with musculoskeletal symptoms (without clinical arthritis) taking part in the Leeds CCP study were analyzed. The presence of bone erosions was evaluated in the classic sites for RA damage: the II and V metacarpophalangeal (MCP) joints, and the V metatarsophalangeal (MTP) joints1. US synovitis was defined as synovial hypertrophy (SH) ≥2 or SH ≥1 + power Doppler signal ≥12. Only subjects with ≥1 follow-up visit were included in the progression analysis (n=400). Progression to IA was defined as the development of clinical synovitis in ≥1 one joint.Results:US bone erosions: prevalence, distribution, and association with subclinical synovitisA total of 2514 joints, in 419 subjects were evaluated.Bone erosions were found in ≥1 joint in 41/419 subjects (9.8%), in 55/2514 joints (2.2%). The prevalence of bone erosions was significantly higher in the V MTP than in the MCP joints (p<0.01). They were detected in 42 V MTP (31 subjects; 7.4%), in 10 II MCP (10 subjects; 2.4%), and in 3 V MCP (3 subjects; 0.7%) joints. US synovitis was detected in 22/55 joints (40%) with bone erosions, in 17/41 subjects (42%). It was found in 48.6% of the V MTP, in 20% of the II MCP and in none of the V MCP joints with bone erosions. A significant correlation between bone erosions and synovitis in the same joint was detected (Cramer’s V=0.22, p<0.01).Seven out of the 55 joints (12.7%) with bone erosions were tender on physical examination: 14.3% of the V MTP, 10% of the II MCP, and none of the V MCP joints.US bone erosions: predicting development of IAA total of 122 subjects (30.5%) developed IA (median follow-up: 301 days, IQR 112-721). The hazard ratios of the US findings for the development of IA (adjusted for age, sex, smoking, anti-CCP and rheumatoid factor titer) are reported in Table 1.Table 1.EverAt 1 yearAt 3 yearsHR (95%CI)P valueHR (95%CI)P valueHR (95%CI)P valuePresence of bone erosion in ≥1 joint (any joint)3.98(1.82-8.7)<0.013.57(1.7-7.5)<0.013.48(1.63-7.4)<0.01- in the II MCP joints2.4(0.52-11.08)0.261.07(0.2-5.76)0.941.67(0.38-7.04)0.5- in the V MCP joints1.37(0.06-31)0.850(N/A)10(N/A)1- in the V MTP joints4.79(1.97-11.63)<0.015.23(2.32-11.8)<0.015.43(2.28-12.92)<0.01Presence of bone erosion and synovitis in the same joint (any joint)3.9(1.19-12.77)0.026.03(2.07-17.55)<0.013.91(1.29-11.85)0.02Presence of bone erosion and synovitis in the same V MTP joint5.08(1.37-18.9)0.027.03(2.28-21.71)<0.014.89(1.48-16.19)<0.01Presence of bone erosion in >1 joint (any joint)10.63(1.87-60.42)<0.015.68(1.66-19.5)<0.017.26(1.67-31.66)<0.01IA free survival rates are showed in Figures 1 and 2.Figure 1.Figure 2.Conclusion:The feet appear to be an early site for damage in individuals at-risk of RA. US bone erosions were mainly detected in asymptomatic joints, but frequently in association with subclinical synovitis. In individuals at-risk of RA, bone erosions in the V MTP joints are more predictive than in the hands (II and V MCP joints) for the development of IA.References:[1] Zayat AS, et al. Ann Rheum Dis. 2015;[2] D’Agostino, et al. RMD Open. 2017;Disclosure of Interests:Andrea Di Matteo Grant/research support from: the publication was conducted while Dr. Di Matteo was an ARTICULUM fellow, Kulveer Mankia: None declared, Laurence Duquenne: None declared, Edoardo Cipolletta: None declared, Richard Wakefield Speakers bureau: Novartis, Janssen, GE, Jacqueline Nam: None declared, Leticia Garcia-Montoya: None declared, Paul Emery Grant/research support from: AbbVie, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, Roche (all paid to employer), Consultant of: AbbVie (consultant, clinical trials, advisor), Bristol-Myers Squibb (consultant, clinical trials, advisor), Lilly (clinical trials, advisor), Merck Sharp & Dohme (consultant, clinical trials, advisor), Novartis (consultant, clinical trials, advisor), Pfizer (consultant, clinical trials, advisor), Roche (consultant, clinical trials, advisor), Samsung (clinical trials, advisor), Sandoz (clinical trials, advisor), UCB (consultant, clinical trials, advisor)
Collapse
|
30
|
Garcia-Montoya L, Nam J, Mankia K, Duquenne L, DI Matteo A, Emery P. THU0558 ANTI-CCP NEGATIVE PATIENTS WITH NEW MUSCULOSKELETAL SYMPTOMS: IMPROVING REFERRALS FROM PRIMARY CARE. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:The presence of anti-cyclic citrullinated peptide antibodies (anti-CCP antibodies) is associated with progression to inflammatory arthritis (IA) [1]; however, most patients attending primary care with a new non-specific musculoskeletal (MSK) complaint and no clinical synovitis have a negative result for this test (CCP-). Considering that only a small proportion of these individuals will be diagnosed with an IA within the next 12 months, predicting disease progression in these patients appears to be more challenging.Objectives:To investigate factors that could be associated with disease progression in patients testing CCP- in order to optimise primary care referrals to Rheumatology.Methods:A prospective observational study recruiting patients over 16 years old with a new MSK complaint and no clinical synovitis was conducted. Patients recruited from primary care centres across the UK from July 2007 until November 2018 were included in this analysis. Those testing negative for the anti-CCP2 assay (initially phadia, later bioplex) were sent questionnaires 1 year later, and GPs were contacted in November 2019 to confirm their disease status.Results:7521 eligible patients were recruited from primary care. 7290 (97%) of them were CCP- and 5678 returned the questionnaire after 1 year. 239 patients (4.2%) of these CCP- reported progression to IA; however, this diagnosis was only confirmed in 53 of them (0.93%). In another 38 patients, the IA diagnosis could not be confirmed and therefore they were not included in the analysis. 21 patients progressed to rheumatoid arthritis (RA), 13 to spondyloarthritis, 11 to polymyalgia rheumatica (requiring disease-modifying anti-rheumatic drugs), 3 to polymyositis, 3 to systemic lupus erythematosus and 2 to systemic sclerosis. Table 1 describes the most troublesome joints and table 2 other concomitant MSK diagnoses of the non-progressors/ progressors; and among the last ones, the RA group. Multivariable analysis showed that pain in specific joints was associated with development of IA within the following 12 months: hand odds ratio (OR) 2.1 [95%CI (1.09-4.16), p=0.027], knee OR 2.0 [95%CI (1.13-3.91), p=0.02], and shoulder OR 1.8 [95%CI (1.02-3.45), p=0.043). Smoking exposure, having a first degree relative with RA and gender were not predictive for progression. Older age showed only a slightly higher risk for IA [OR 1.04, 95%CI (1.01-1.06) p=0.001].Table 1.Characteristics, troublesome joints of the participantsNON-PROGRESSORS(n=5588)PROGRESSORS (n=52)RA progressors (n=21)Carpal tunnel syndrome%131730Rotator cuff %121920Trigger finger %540Tennis elbow %15105Osteoarthritis %182520Table 2.Concomitant MSK diagnosisNON-PROGRESSORS(n=5588)PROGRESSORS (n=52)RA progressors (n=21)Female %725857Mean age y.o.53 (16-91)60 (30-82)60 (30-82)FDR with RA %383333Ever Smoked %384340Neck pain %302914Shoulder pain %415852Elbow pain %293829Wrist pain %384648Hand pain %537176Thumb pain %364857Back pain %332524Hip pain %362919Knee pain %557162Ankle pain %302324Foot pain %344033Conclusion:In CCP- patients without clinical synovitis, hand, knee and shoulder pain should be investigated more carefully as these involve a higher risk of progression to IA. Patient reported outcomes regarding rheumatic diseases are not reliable; the distribution of joint pain seems to be a more useful tool than the family history when assessing the need for referral to Rheumatology.References:[1]Rakieh C. Ann Rheum Dis. 2015;74:1659-66Acknowledgments:National Institute of Health Research (NIHR)Leeds Biomedical Research Centre (BRC)Disclosure of Interests:Leticia Garcia-Montoya: None declared, Jacqueline Nam: None declared, Kulveer Mankia: None declared, Laurence Duquenne: None declared, Andrea Di Matteo Grant/research support from: the publication was conducted while Dr. Di Matteo was an ARTICULUM fellow, Paul Emery Grant/research support from: AbbVie, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, Roche (all paid to employer), Consultant of: AbbVie (consultant, clinical trials, advisor), Bristol-Myers Squibb (consultant, clinical trials, advisor), Lilly (clinical trials, advisor), Merck Sharp & Dohme (consultant, clinical trials, advisor), Novartis (consultant, clinical trials, advisor), Pfizer (consultant, clinical trials, advisor), Roche (consultant, clinical trials, advisor), Samsung (clinical trials, advisor), Sandoz (clinical trials, advisor), UCB (consultant, clinical trials, advisor)
Collapse
|
31
|
Prohira S, de Vries KD, Allison P, Beatty J, Besson D, Connolly A, van Eijndhoven N, Hast C, Kuo CY, Latif UA, Meures T, Nam J, Nozdrina A, Ralston JP, Riesen Z, Sbrocco C, Torres J, Wissel S. Observation of Radar Echoes from High-Energy Particle Cascades. PHYSICAL REVIEW LETTERS 2020; 124:091101. [PMID: 32202874 DOI: 10.1103/physrevlett.124.091101] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2019] [Accepted: 01/17/2020] [Indexed: 06/10/2023]
Abstract
We report the observation of radar echoes from the ionization trails of high-energy particle cascades. Data were taken at the SLAC National Accelerator Laboratory, where the full electron beam (∼10^{9} e^{-} at ∼10 GeV/e^{-}) was directed into a plastic target to simulate an ultrahigh-energy neutrino interaction. The target was interrogated with radio waves, and coherent radio reflections from the cascades were detected with properties consistent with theoretical expectations. This is the first definitive observation of radar echoes from high-energy particle cascades, which may lead to a viable neutrino detection technology for energies ≳10^{16} eV.
Collapse
|
32
|
Kim D, Lee S, Hong W, Lee H, Jeon S, Han S, Nam J. Image Segmentation for FIB-SEM Serial Sectioning of a Si/C-Graphite Composite Anode Microstructure Based on Preprocessing and Global Thresholding. MICROSCOPY AND MICROANALYSIS : THE OFFICIAL JOURNAL OF MICROSCOPY SOCIETY OF AMERICA, MICROBEAM ANALYSIS SOCIETY, MICROSCOPICAL SOCIETY OF CANADA 2019; 25:1139-1154. [PMID: 31387658 DOI: 10.1017/s1431927619014752] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The choice of materials that constitute electrodes and the way they are interconnected, i.e., the microstructure, influences the performance of lithium-ion batteries. For batteries with high energy and power densities, the microstructure of the electrodes must be controlled during their manufacturing process. Moreover, understanding the microstructure helps in designing a high-performance, yet low-cost battery. In this study, we propose a systematic algorithm workflow for the images of the microstructure of anodes obtained from a focused ion beam scanning electron microscope (FIB-SEM). Here, we discuss the typical issues that arise in the raw FIB-SEM images and the corresponding preprocessing methods that resolve them. Next, we propose a Fourier transform-based filter that effectively reduces curtain artifacts. Also, we propose a simple, yet an effective, global-thresholding method to identify active materials and pores in the microstructure. Finally, we reconstruct the three-dimensional structures by concatenating the segmented images. The whole algorithm workflow used in this study is not fully automated and requires user interactions such as choosing the values of parameters and removing shine-through artifacts manually. However, it should be emphasized that the proposed global-thresholding method is deterministic and stable, which results in high segmentation performance for all sectioning images.
Collapse
|
33
|
Cho Y, Chung I, Nam J, Jung Y. Is additive treatment necessary for patients with a positive lateral margin after endoscopic submucosal dissection of early gastric cancer? Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Ahn WG, Lee SH, Nam J, Chun B, Jung HW. Simultaneous Analysis of Die Internal and External Flows in Slot Coating Process. JOURNAL OF CHEMICAL ENGINEERING OF JAPAN 2019. [DOI: 10.1252/jcej.17we313] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
35
|
Lee M, Hong S, Kim D, Kim E, Lim K, Jung JC, Richter H, Moon JH, Choi N, Nam J, Choi J. Chabazite-Type Zeolite Membranes for Effective CO 2 Separation: The Role of Hydrophobicity and Defect Structure. ACS APPLIED MATERIALS & INTERFACES 2019; 11:3946-3960. [PMID: 30614677 DOI: 10.1021/acsami.8b18854] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Chabazite (CHA)-type zeolites are promising for the separation of CO2 from larger molecules, such as N2 (relevant to postcombustion carbon capture) and CH4 (relevant to natural gas/biogas upgrading). In particular, the pore size of CHA zeolites (0.37 × 0.42 nm2) can recognize slight molecular size differences between CO2 (0.33 nm) and the larger N2 (0.364 nm) or CH4 (0.38 nm) molecules, thus allowing separation in favor of CO2 through CHA membranes. Furthermore, the siliceous constituents in the CHA zeolite can reduce the adsorption capacity toward the smaller H2O molecule (0.265 nm) and, thus, the H2O permeation rate. This is highly desirable for securing good molecular sieving ability with CO2 permselectivity in the presence of H2O vapor. Indeed, a siliceous CHA film obtained with a nominal Si/Al ratio of 100 (CHA_100) showed high CO2/N2 and CO2/CH4 separation performance, especially in the presence of H2O vapor; ∼13.4 CO2/N2 and ∼37 CO2/CH4 separation factors (SFs) at 30 °C. These SFs were higher than the corresponding values (∼5.2 CO2/CH4 SFs and ∼31 CO2/CH4 SFs) under dry conditions; such improvement could be ascribed to defect blocking by physisorbed water molecules. Finally, the contribution of molecular transport through zeolitic and nonzeolitic parts was quantitatively analyzed by combining information extracted from image processing of fluorescence confocal optical microscopy images with a one-dimensional permeation model. It appears that ∼19 and ∼20% of the total CO2 permeance for CHA_100 were reduced due to transport inhibition by the physisorbed water molecules on the membrane surface and defect, respectively.
Collapse
|
36
|
Hong S, Kim D, Richter H, Moon JH, Choi N, Nam J, Choi J. Quantitative elucidation of the elusive role of defects in polycrystalline MFI zeolite membranes on xylene separation performance. J Memb Sci 2019. [DOI: 10.1016/j.memsci.2018.10.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
37
|
Park S, Lee H, Kim D, Nam J. Vaginal Approach (Colpotomy and Tumor Extraction) in Robotic Radical Hysterectomy Should be a Preferred Method in Cervical Cancer: A Study of 31 Cases. J Minim Invasive Gynecol 2018. [DOI: 10.1016/j.jmig.2018.09.735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Kim Y, Lee Y, Kim D, Lee S, Park J, Suh D, Kim J, Kim Y, Nam J. Patterns of Recurrence and Survival of Node-Positive Cervical Cancer After Open Versus Laparoscopic Radical Surgery. J Minim Invasive Gynecol 2018. [DOI: 10.1016/j.jmig.2018.09.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
39
|
Gorham PW, Rotter B, Allison P, Banerjee O, Batten L, Beatty JJ, Bechtol K, Belov K, Besson DZ, Binns WR, Bugaev V, Cao P, Chen CC, Chen CH, Chen P, Clem JM, Connolly A, Cremonesi L, Dailey B, Deaconu C, Dowkontt PF, Fox BD, Gordon JWH, Hast C, Hill B, Hughes K, Huang JJ, Hupe R, Israel MH, Javaid A, Lam J, Liewer KM, Lin SY, Liu TC, Ludwig A, Macchiarulo L, Matsuno S, Miki C, Mulrey K, Nam J, Naudet CJ, Nichol RJ, Novikov A, Oberla E, Olmedo M, Prechelt R, Prohira S, Rauch BF, Roberts JM, Romero-Wolf A, Russell JW, Saltzberg D, Seckel D, Schoorlemmer H, Shiao J, Stafford S, Stockham J, Stockham M, Strutt B, Varner GS, Vieregg AG, Wang SH, Wissel SA. Observation of an Unusual Upward-Going Cosmic-Ray-like Event in the Third Flight of ANITA. PHYSICAL REVIEW LETTERS 2018; 121:161102. [PMID: 30387639 DOI: 10.1103/physrevlett.121.161102] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2018] [Revised: 06/14/2018] [Indexed: 06/08/2023]
Abstract
We report on an upward traveling, radio-detected cosmic-ray-like impulsive event with characteristics closely matching an extensive air shower. This event, observed in the third flight of the Antarctic Impulsive Transient Antenna (ANITA), a NASA-sponsored long-duration balloon payload, is consistent with a similar event reported in a previous flight. These events could be produced by the atmospheric decay of an upward-propagating τ lepton produced by a ν_{τ} interaction, although their relatively steep arrival angles create tension with the standard model neutrino cross section. Each of the two events have a posteriori background estimates of ≲10^{-2} events. If these are generated by τ-lepton decay, then either the charged-current ν_{τ} cross section is suppressed at EeV energies, or the events arise at moments when the peak flux of a transient neutrino source was much larger than the typical expected cosmogenic background neutrinos.
Collapse
|
40
|
Ondhia U, Conter H, Owen S, Zhou A, Nam J, Singh S, Abdulla A, Chu P, Felizzi F, Sangha R. P3.04-17 Cost-Effectiveness of Atezolizumab for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Canada. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
41
|
Ico G, Myung A, Kim BS, Myung NV, Nam J. Transformative piezoelectric enhancement of P(VDF-TrFE) synergistically driven by nanoscale dimensional reduction and thermal treatment. NANOSCALE 2018; 10:2894-2901. [PMID: 29368772 DOI: 10.1039/c7nr08296g] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Despite the significant potential of organic piezoelectric materials in the electro-mechanical or mechano-electrical applications that require light and flexible material properties, the intrinsically low piezoelectric performance as compared to traditional inorganic materials has limited their full utilization. In this study, we demonstrate that dimensional reduction of poly(vinylidene fluoride trifluoroethylene) (P(VDF-TrFE)) at the nanoscale by electrospinning, combined with an appropriate thermal treatment, induces a transformative enhancement in piezoelectric performance. Specifically, the piezoelectric coefficient (d33) reached up to -108 pm V-1, approaching that of inorganic counterparts. Electrospun mats composed of thermo-treated 30 nm nanofibers with a thickness of 15 μm produced a consistent peak-to-peak voltage of 38.5 V and a power output of 74.1 μW at a strain of 0.26% while sustaining energy production over 10k repeated actuations. The exceptional piezoelectric performance was realized by the enhancement of piezoelectric dipole alignment and the materialization of flexoelectricity, both from the synergistic effects of dimensional reduction and thermal treatment. Our findings suggest that dimensionally controlled and thermally treated electrospun P(VDF-TrFE) nanofibers provide an opportunity to exploit their flexibility and durability for mechanically challenging applications while matching the piezoelectric performance of brittle, inorganic piezoelectric materials.
Collapse
|
42
|
Lim T, Ico G, Jung K, Bozhilov KN, Nam J, Martinez-Morales AA. Crystal growth and piezoelectric characterization of mechanically stable ZnO nanostructure arrays. CrystEngComm 2018. [DOI: 10.1039/c8ce00799c] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The highest piezoelectric performance of ZnO can be achieved by utilizing the piezoelectric operation along the c-axis due to its anisotropic permanent dipole moment.
Collapse
|
43
|
Lee JH, Choi WS, Jeen H, Lee HJ, Seo JH, Nam J, Yeom MS, Lee HN. Strongly Coupled Magnetic and Electronic Transitions in Multivalent Strontium Cobaltites. Sci Rep 2017; 7:16066. [PMID: 29167490 PMCID: PMC5700177 DOI: 10.1038/s41598-017-16246-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2017] [Accepted: 10/13/2017] [Indexed: 12/21/2022] Open
Abstract
The topotactic phase transition in SrCoOx (x = 2.5–3.0) makes it possible to reversibly transit between the two distinct phases, i.e. the brownmillerite SrCoO2.5 that is a room-temperature antiferromagnetic insulator (AFM-I) and the perovskite SrCoO3 that is a ferromagnetic metal (FM-M), owing to their multiple valence states. For the intermediate x values, the two distinct phases are expected to strongly compete with each other. With oxidation of SrCoO2.5, however, it has been conjectured that the magnetic transition is decoupled to the electronic phase transition, i.e., the AFM-to-FM transition occurs before the insulator-to-metal transition (IMT), which is still controversial. Here, we bridge the gap between the two-phase transitions by density-functional theory calculations combined with optical spectroscopy. We confirm that the IMT actually occurs concomitantly with the FM transition near the oxygen content x = 2.75. Strong charge-spin coupling drives the concurrent IMT and AFM-to-FM transition, which fosters the near room-T magnetic transition characteristic. Ultimately, our study demonstrates that SrCoOx is an intriguingly rare candidate for inducing coupled magnetic and electronic transition via fast and reversible redox reactions.
Collapse
|
44
|
Lim GH, Ahn K, Bok S, Nam J, Lim B. Curving silver nanowires using liquid droplets for highly stretchable and durable percolation networks. NANOSCALE 2017; 9:8938-8944. [PMID: 28654124 DOI: 10.1039/c7nr02615c] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Silver (Ag) nanowires (NWs) are promising building blocks for the fabrication of stretchable electrodes, but they may undergo mechanical fracture at low tensile strains, which leads to degradation in electrical performance of Ag NW-based stretchable electrodes. Here we report on a simple route to create the percolation networks of Ag NW rings via a conventional spray coating process. We discovered that Ag NWs can be bent into curved shapes within micrometer-sized liquid droplets generated during the spraying process due to elasto-capillary interaction. This curving phenomenon allowed the deposition of Ag NW rings directly on a desired substrate without the need for any complicated process. The network of Ag NW rings effectively releases the applied tensile strains thanks to curved shapes of the constituent NWs, enabling the achievement of excellent electromechanical stability as well as high stretchability. Our approach not only provides a simple, low cost, and scalable route to the fabrication of high-performance Ag NW-based stretchable electrodes, but also opens a new and useful way of engineering the structure of NWs for various applications.
Collapse
|
45
|
Cheng Z, Do T, Mankia K, Meade J, Hunt L, Nam J, Tugnait A, Speirs A, Clerehugh V, Emery P, Devine D. The subgingival microbiomes in periodontitis and health of individuals with rheumatoid arthritis and at risk of developing rheumatoid arthritis. J Oral Microbiol 2017. [PMCID: PMC5646645 DOI: 10.1080/20002297.2017.1325216] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
Serum anti-citrullinated protein antibodies (ACPAs), present in 70% of people with rheumatoid arthritis (RA), can be detected ≤10years before the onset of clinical disease. RA and periodontitis are epidemiologically associated and we have reported a high incidence of periodontitis in people who are ACPA+ and at risk of RA. Periodontal bacteria may contribute by multiple routes to the generation of RA-autoantibodies. This study aims to characterise the subgingival microbiomes from periodontitis and health in individuals with/without RA and at risk of RA. Forty-five ACPA+ no RA (RA-at-risk; RAR), 31 healthy controls (HC) and 30 ACPA+ RA patients (RA) underwent a periodontal examination. DNA from subgingival plaque from healthy and deep pocket sites were paired-end sequenced using the Illumina HiSeq3000 and data analysed using MG-RAST + DESeq. Metagenomes in RA samples had high proportions of Actinobacteria; RAR microbiomes contained higher proportions of Bacteroidetes than HC. The relative abundance of P. gingivalis was high in periodontitis and RAR; Aggregatibacter actinomycetemcomitans was detected with similar frequency in each group. Other bacteria implicated in periodontitis and/or autoantibody generation (Filifactor alocis, Prevotella spp, Leptotrichia spp.) were detected. Analyses are on-going to elucidate the diversity and functional potential of the subgingival microbiome associated with RA.
Collapse
|
46
|
|
47
|
Sinclair D, Featherstone R, Naschek M, Nam J, Du A, Wright S, Pance K, Melnychenko O, Weger R, Akuzawa S, Matsumoto M, Siegel SJ. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome. eNeuro 2017; 4:ENEURO.0380-16.2017. [PMID: 28451631 PMCID: PMC5394929 DOI: 10.1523/eneuro.0380-16.2017] [Citation(s) in RCA: 61] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2016] [Revised: 02/09/2017] [Accepted: 02/13/2017] [Indexed: 12/15/2022] Open
Abstract
Fragile X syndrome is a genetic condition resulting from FMR1 gene mutation that leads to intellectual disability, autism-like symptoms, and sensory hypersensitivity. Arbaclofen, a GABA-B agonist, has shown efficacy in some individuals with FXS but has become unavailable after unsuccessful clinical trials, prompting interest in publicly available, racemic baclofen. The present study investigated whether racemic baclofen can remediate abnormalities of neural circuit function, sensory processing, and behavior in Fmr1 knockout mice, a rodent model of fragile X syndrome. Fmr1 knockout mice showed increased baseline and auditory-evoked high-frequency gamma (30-80 Hz) power relative to C57BL/6 controls, as measured by electroencephalography. These deficits were accompanied by decreased T maze spontaneous alternation, decreased social interactions, and increased open field center time, suggestive of diminished working memory, sociability, and anxiety-like behavior, respectively. Abnormal auditory-evoked gamma oscillations, working memory, and anxiety-related behavior were normalized by treatment with baclofen, but impaired sociability was not. Improvements in working memory were evident predominantly in mice whose auditory-evoked gamma oscillations were dampened by baclofen. These findings suggest that racemic baclofen may be useful for targeting sensory and cognitive disturbances in fragile X syndrome.
Collapse
|
48
|
Lim S, Cho B, Bae J, Kim AR, Lee KH, Kim SH, Hahm MG, Nam J. Electrohydrodynamic printing for scalable MoS2 flake coating: application to gas sensing device. NANOTECHNOLOGY 2016; 27:435501. [PMID: 27658490 DOI: 10.1088/0957-4484/27/43/435501] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Scalable sub-micrometer molybdenum disulfide ([Formula: see text]) flake films with highly uniform coverage were created using a systematic approach. An electrohydrodynamic (EHD) printing process realized a remarkably uniform distribution of exfoliated [Formula: see text] flakes on desired substrates. In combination with a fast evaporating dispersion medium and an optimal choice of operating parameters, the EHD printing can produce a film rapidly on a substrate without excessive agglomeration or cluster formation, which can be problems in previously reported liquid-based continuous film methods. The printing of exfoliated [Formula: see text] flakes enabled the fabrication of a gas sensor with high performance and reproducibility for [Formula: see text] and [Formula: see text].
Collapse
|
49
|
Leyland AH, Ouédraogo S, Gray R, Bond L, Briggs AH, Nam J, Wood R, Dundas R. OP86 Evaluating Health in Pregnancy grants in Scotland: a natural experiment. Br J Soc Med 2016. [DOI: 10.1136/jech-2016-208064.86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
50
|
Gorham PW, Nam J, Romero-Wolf A, Hoover S, Allison P, Banerjee O, Beatty JJ, Belov K, Besson DZ, Binns WR, Bugaev V, Cao P, Chen C, Chen P, Clem JM, Connolly A, Dailey B, Deaconu C, Cremonesi L, Dowkontt PF, DuVernois MA, Field RC, Fox BD, Goldstein D, Gordon J, Hast C, Hebert CL, Hill B, Hughes K, Hupe R, Israel MH, Javaid A, Kowalski J, Lam J, Learned JG, Liewer KM, Liu TC, Link JT, Lusczek E, Matsuno S, Mercurio BC, Miki C, Miočinović P, Mottram M, Mulrey K, Naudet CJ, Ng J, Nichol RJ, Palladino K, Rauch BF, Reil K, Roberts J, Rosen M, Rotter B, Russell J, Ruckman L, Saltzberg D, Seckel D, Schoorlemmer H, Stafford S, Stockham J, Stockham M, Strutt B, Tatem K, Varner GS, Vieregg AG, Walz D, Wissel SA, Wu F. Characteristics of Four Upward-Pointing Cosmic-Ray-like Events Observed with ANITA. PHYSICAL REVIEW LETTERS 2016; 117:071101. [PMID: 27563945 DOI: 10.1103/physrevlett.117.071101] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/11/2016] [Indexed: 06/06/2023]
Abstract
We report on four radio-detected cosmic-ray (CR) or CR-like events observed with the Antarctic Impulsive Transient Antenna (ANITA), a NASA-sponsored long-duration balloon payload. Two of the four were previously identified as stratospheric CR air showers during the ANITA-I flight. A third stratospheric CR was detected during the ANITA-II flight. Here, we report on characteristics of these three unusual CR events, which develop nearly horizontally, 20-30 km above the surface of Earth. In addition, we report on a fourth steeply upward-pointing ANITA-I CR-like radio event which has characteristics consistent with a primary that emerged from the surface of the ice. This suggests a possible τ-lepton decay as the origin of this event, but such an interpretation would require significant suppression of the standard model τ-neutrino cross section.
Collapse
|